These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3363220)

  • 1. Cyclosporine disposition in the hyperlipidemic rat model.
    Brunner LJ; Vadiei K; Luke DR
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):339-48. PubMed ID: 3363220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker rats.
    Todd EL; Abernethy DR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):642-7. PubMed ID: 3735134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat.
    Megalli S; Davies NM; Roufogalis BD
    J Pharm Pharm Sci; 2006; 9(3):281-91. PubMed ID: 17207412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model.
    Vadiei K; Lopez-Berestein G; Luke DR
    Int J Obes; 1990 Jun; 14(6):465-72. PubMed ID: 2401582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
    Brocks DR; Ala S; Aliabadi HM
    Biopharm Drug Dispos; 2006 Jan; 27(1):7-16. PubMed ID: 16278928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased extravasation of macromolecules in skeletal muscles of the Zucker rat model.
    St-Pierre P; Bouffard L; Papirakis ME; Maheux P
    Obesity (Silver Spring); 2006 May; 14(5):787-93. PubMed ID: 16855187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral hypothalamic serotonergic responsiveness to food intake in rat obesity as measured by microdialysis.
    Mori RC; Guimarães RB; Nascimento CM; Ribeiro EB
    Can J Physiol Pharmacol; 1999 Apr; 77(4):286-92. PubMed ID: 10535677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry.
    Plumb RS; Johnson KA; Rainville P; Shockcor JP; Williams R; Granger JH; Wilson ID
    Rapid Commun Mass Spectrom; 2006; 20(19):2800-6. PubMed ID: 16941721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course and dynamics of adipose tissue development in obese and lean Zucker rat pups.
    Pouteau E; Turner S; Aprikian O; Hellerstein M; Moser M; Darimont C; Fay LB; Macé K
    Int J Obes (Lond); 2008 Apr; 32(4):648-57. PubMed ID: 18087263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.
    Blouin RA; Dickson P; McNamara PJ; Cibull M; McClain C
    J Pharmacol Exp Ther; 1987 Nov; 243(2):565-70. PubMed ID: 3681696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat.
    Sherman WM; Friedman JE; Gao JP; Reed MJ; Elton CW; Dohm GL
    Med Sci Sports Exerc; 1993 Mar; 25(3):341-8. PubMed ID: 8455449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
    Chaudhary IP; Tuntaterdtum S; McNamara PJ; Robertson LW; Blouin RA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1333-8. PubMed ID: 8510012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 24-h food deprivation on lipoprotein composition and oleoyl-estrone content of lean and obese Zucker rats.
    Peinado-Onsurbe J; Blay M; Casadomé L; Fernández-López JA; Remesar X; Alemany M
    Eur J Nutr; 2001 Aug; 40(4):155-60. PubMed ID: 11905956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effect of cyclosporine in the hyperlipidemic rat model.
    Luke DR
    Biopharm Drug Dispos; 1992 Dec; 13(9):635-45. PubMed ID: 1467451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-associated N-myristoyltransferase activity is reduced in obese (fa/fa) Zucker rat liver.
    King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK
    Biochem Biophys Res Commun; 1993 Oct; 196(2):665-70. PubMed ID: 8240341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of D-fenfluramine in lean and obese rats.
    Fracasso C; Guiso G; Garattini S; Caccia S
    Appetite; 1988 Feb; 10(1):45-55. PubMed ID: 3355126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial lipid biochemistry in the spontaneously hyperlipidemic Zucker rat and its similarity to early atherogenesis.
    St John LC; Bell FP
    Atherosclerosis; 1991 Feb; 86(2-3):139-44. PubMed ID: 1872908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.